Paris, France, June 5, 2025 — TISSIUM, a medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection for the sixth year in a row in the French Tech 120 Program by joining the 2025 class. Launched in 2019 by the Mission French Tech, the French Tech 120 is a program from the Government to support the 120 most promising French start-ups, who have the potential to become world-class technology leaders. TISSIUM will benefit from daily, personalized sRead More
